High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis (Q24655731)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

Kris V Kowdley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

18

Tanya Hoskin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Keith D Lindor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Velimir A C Luketic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Edwyn Harrison

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Timothy McCashland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Alex S Befeler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Denise Harnois

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Roberta Jorgensen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jan Petz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jill Keach

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jody Mooney

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Carol Sargeant

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Julie Braaten

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Tamara Bernard

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Debra King

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Ellen Miceli

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jeff Schmoll

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Prabin Thapa

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

808-814

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

2 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758780

Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758780

Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758780

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758780

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community

30 May 2018

1 reference

Colchicine treatment of primary sclerosing cholangitis

21 January 2018

1 reference

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

21 January 2018

1 reference

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

21 January 2018

1 reference

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

21 January 2018

1 reference

A revised natural history model for primary sclerosing cholangitis

21 January 2018

1 reference

12 December 2020

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver

1 reference

12 December 2020

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

1 reference

12 December 2020

Tacrolimus for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Identifiers

DOI

10.1002/HEP.23082

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19585548%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2 references